Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
While further clinical trials with long-term follow-up periods are still required, ALC appears to be a safe, well-tolerated, and effective potential treatment option for DPN
References: 1. Bush JR et al
As the oncology peptide segment grows at 12.76% CAGR and CNS/neuropeptide and immunology/rare disease segments each grow at 10%+ annually, these high-value complex modalities will become an increasingly important revenue source for the most technically advanced manufacturers.
Their identification of the amino acid sequence of the biologically active GLP-1 hormone laid the groundwork for drugs in the management of type 2 diabetes
US$ 26.39
US$ 21.62
US$ 26.72
US$ 29.47
US$ 21.53
